A pharmaceutical company successfully protected one of its products in a patent infringement abbreviated new drug application (ANDA) lawsuit against defendants for their anticipated marketing of a generic version of a drug. Alison Baldwin led the litigation team that represented the pharmaceutical company in the matter, succeeding both in district court and on appeal.
Pharmaceutical Company Protects Product in ANDA Litigation
Lead Contacts
